85 results match your criteria: "Centre Hospitalier de Perpignan[Affiliation]"

Immune checkpoint inhibitors-associated vasculitis: a heterogeneous condition with possible severe disease course.

Rheumatology (Oxford)

December 2024

AP-HP, Université Paris Saclay, department of internal medicine and clinical immunology, Bicêtre Hospital, Le Kremlin Bicêtre, France.

Objective: To describe presentation, treatment and outcome of immune checkpoint inhibitor (ICI) associated-vasculitis in cancer patients in a multicentre study.

Methods: Thanks to the ImmunoCancer International Registry (ICIR), a multidisciplinary network focused on the research of the immune related adverse events related to cancer immunotherapies, patients presenting with a clinical and/or radiological suspicion of vasculitis, and histological evidence of vasculitis after being exposed to ICIs were retrospectively identified.

Results: Twenty eight cases were identified in the ICIR registry.

View Article and Find Full Text PDF

Hepatitis C virus (HCV) is an important cause of chronic liver disease. Among at-risk populations, access to care is challenging. The French Ministry of Health has supported a seek-and-treat pilot intervention aiming at micro-elimination in Perpignan, France, to inform scale-up of elimination efforts across the whole territory.

View Article and Find Full Text PDF

Background: Appropriate prescription of Proton pump inhibitors (PPIs) remains an important concern amid the rising overuse. A gap exists in the literature regarding the benefit of PPI prophylaxis and the consequences of underprescription in patients at risk for upper gastrointestinal bleeding (UGIB).

Aims: This study aims to describe the characteristics of hemorrhage in relation to PPI use in patients experiencing UGIB, with a focus on high-risk individuals requiring gastroprotection.

View Article and Find Full Text PDF
Article Synopsis
  • * This study analyzed cases of C bantiana infections in France and its territories, involving patients who were diagnosed through a comprehensive surveillance program, focusing on survival rates and the presence of central nervous system (CNS) involvement.
  • * Out of 23 patients identified from 2002 to 2022, 65% had CNS involvement, with a notable increase in cases reported in 2022, indicating a possible correlation with environmental factors like rising temperatures.
View Article and Find Full Text PDF

: Liver venous deprivation (LVD) is a recent radiological technique that has shown promising results on Future Remnant Liver (FRL) hypertrophy. The aim of this retrospective study is to compare the segmentary hypertrophy of the FRL after LVD and after portal vein embolization (PVE). : Patients undergoing PVE or LVD between April 2015 and April 2020 were included.

View Article and Find Full Text PDF

Background: In geriatrics, explicit criteria for potentially inappropriate prescriptions (PIPs) are useful for optimizing drug use.

Objective: To produce an expert consensus on explicit definitions of antibiotic-PIPs for hospitalized older patients.

Methods: We conducted a Delphi survey involving French experts on antibiotic stewardship in hospital settings.

View Article and Find Full Text PDF

Characteristics and incidence of infections in patients with multiple myeloma treated by bispecific antibodies: a national retrospective study.

Clin Microbiol Infect

June 2024

Service de Maladies Infectieuses et Tropicales, Centre Hospitalo-universitaire (CHU) de Toulouse, France; Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity) INSERM, Université Toulouse III, Toulouse, France. Electronic address:

Article Synopsis
  • Bispecific antibodies (BsAbs) are used to treat relapsed or refractory multiple myeloma, but frequent infections were noted during clinical trials, indicating a need for further real-world data on infection risks and outcomes.
  • A multicenter retrospective study involving 229 patients in France from December 2020 to February 2023 found a high incidence of infections, with 234 recorded cases, primarily affecting the respiratory system, and a hospitalization rate of 56%.
  • The study identified corticosteroids used for managing cytokine release syndrome as a risk factor for infections, while using GPRC5D-targeting BsAbs and antibacterial prophylaxis was associated with a reduced risk.
View Article and Find Full Text PDF
Article Synopsis
  • Recent findings show that mutations in the UBA1 gene are linked to VEXAS syndrome, an adult-onset auto-inflammatory condition, but the exact effects of these mutations are not well understood.
  • Research on a group of VEXAS patients indicates that their monocytes are not functioning properly and exhibit signs of exhaustion and altered chemokine receptor expression.
  • The study also highlights elevated levels of inflammatory cytokines in the blood of VEXAS patients, pointing to possible therapeutic targets related to inflammasome activation and inflammatory cell death.
View Article and Find Full Text PDF

IgG4-related uveitis. A French cohort and literature review.

Semin Arthritis Rheum

February 2024

Médecine interne, Hôpital de la Timone, AP-HM, Aix-Marseille Université, Marseille, France.

Introduction: IgG4-related disease (IgG4-RD) is a fibro-inflammatory disorder that can affect almost any organ. IgG4-related ophthalmic disease is a protean condition involving the orbit and ocular adnexa. Although a few cases of uveitis have been reported, the exact pattern of IgG4-related intraocular manifestations remains unclear.

View Article and Find Full Text PDF

Purpose: The purpose of this study was to compare the performance of Precise IQ Engine (PIQE) and Advanced intelligent Clear-IQ Engine (AiCE) algorithms on image-quality according to the dose level in a cardiac computed tomography (CT) protocol.

Materials And Methods: Acquisitions were performed using the CT ACR 464 phantom at three dose levels (volume CT dose indexes: 7.1/5.

View Article and Find Full Text PDF

Systemic relapses of primary CNS lymphomas (PCNSL): a LOC network study.

Ann Hematol

May 2023

Hôpital Pitié-Salpêtrière, Service de Neurologie 2-Mazarin, APHP, Sorbonne Université, IHU, ICM, Paris, France.

Primary central nervous system lymphomas (PCNSLs) classically remain confined within the CNS throughout their evolution for unknown reasons. Our objective was to analyse the rare extracerebral relapses of PCNSL in a nationwide population-based study. We retrospectively selected PCNSL patients who experienced extracerebral relapse during their follow-up from the French LOC database.

View Article and Find Full Text PDF

Robotic versus open total pancreatectomy: a systematic review and meta-analysis.

J Robot Surg

August 2023

Department of Surgery, Medical Faculty Mannheim, Universitätsmedizin Mannheim, Heidelberg University, Heidelberg, Germany.

Limited data are available on postoperative outcomes in patients undergoing robotic total pancreatectomy (RTP). This systematic review and meta-analysis aimed to compare the postoperative outcomes of RTP and open total pancreatectomy (OTP). We performed a systematic review with meta-analysis according to the PRISMA 2020 and AMSTAR 2 guidelines.

View Article and Find Full Text PDF

[The 2022-2026 Transplantation Plan: objectives and priorities for a new development of kidney transplantation].

Nephrol Ther

March 2023

CHU de Saint-Étienne, service de néphrologie, Avenue Albert Raimond, 42270 Saint-Priesten-Jarez, France

The 2022-2026 Transplantation Plan has been launched by the French government to stimulate the activities of organ harvesting and transplantation, after the failure of the previous one. It has been designed by the Biomedicine Agency in collaboration with learning societies, including the SFNDT, and patient associations. The plan is original in its objectives, its regional organization with its driving by the Regional Health Agencies, the involvement of advanced practice nurses and its funding.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the prevalence and incidence of hepatitis E virus (HEV) infection in patients with inflammatory bowel disease (IBD) undergoing immunomodulatory treatment, given that these medications can compromise the immune system.
  • Conducted across 16 French centers, the research involved 488 IBD patients, revealing very few cases of acute HEV infection, with a seroprevalence of 14.2% for chronic infection, particularly among older patients and those with higher seafood intake.
  • The findings suggest that routine HEV screening isn't necessary for IBD patients on immunomodulators, but HEV should be tested if liver abnormalities occur.
View Article and Find Full Text PDF

Background: The optimal duration of antimicrobial therapy for urinary tract infections (UTIs) in men remains controversial.

Methods: To compare 7 days to 14 days of total antibiotic treatment for febrile UTIs in men, this multicenter randomized, double-blind. placebo-controlled noninferiority trial enrolled 282 men from 27 centers in France.

View Article and Find Full Text PDF

Background: The practice of regular physical activity can reduce the incidence of certain cancers (colon, breast, and prostate) and improve overall survival after treatment by reducing fatigue and the risk of relapse. This impact on survival has only been demonstrated in active patients with lymphoma before and after treatment. As poor general health status reduces the chances of survival and these patients are most likely to also have sarcopenia, it is important to be able to improve their physical function through adapted physical activity (APA) as part of supportive care management.

View Article and Find Full Text PDF

Information on causes of death (CoDs) and the impact of myelodysplastic syndromes (MDS) on survival in patients with lower-risk MDS (LR-MDS) is limited. A better understanding of the relationship between disease characteristics, clinical interventions and CoDs may improve outcomes of patients with LR-MDS. We prospectively collected data on patients with LR-MDS in the European MDS registry from 2008 to 2019.

View Article and Find Full Text PDF

Background: We recently reported a worrying 30% rate of early neurological deterioration (END) occurring within 24 hours following intravenous thrombolysis (IVT) in minor stroke with isolated internal carotid artery occlusion (ie, without additional intracranial occlusion), mainly due to artery-to-artery embolism. Here, we hypothesize that in this setting IVT-as compared to no-IVT-may foster END, in particular by favoring artery-to-artery embolism from thrombus fragmentation.

Methods: From a large multicenter retrospective database, we compared minor stroke (National Institutes of Health Stroke Scale score <6) isolated internal carotid artery occlusion patients treated within 4.

View Article and Find Full Text PDF

JCO We previously reported the results of a randomized phase II study in patients with newly diagnosed primary CNS lymphoma (age 18-60 years). Patients were treated with high-dose methotrexate-based induction chemotherapy followed by whole-brain radiotherapy (WBRT) or high-dose chemotherapy (thiotepa-busulfan-cyclophosphamide) with autologous stem-cell transplantation (ASCT). The median follow-up was 33 months.

View Article and Find Full Text PDF

Introduction: COVID-19 is responsible of severe hypoxaemia and acute respiratory distress syndrome (ARDS). Prone positioning improves oxygenation and survival in sedated mechanically patients with ARDS not related to COVID-19. Awake prone positioning is a simple and safe technique which improves oxygenation in non-intubated COVID-19 patients.

View Article and Find Full Text PDF

Isolated intraocular relapses of primary cerebral lymphomas: An LOC network study.

Hematol Oncol

December 2022

Neurology, Assistance Publique - Hôpitaux de Paris (APHP), Sorbonne Université, IHU, ICM, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.

Article Synopsis
  • - Most relapses of primary central nervous system lymphoma (PCNSL) typically occur in the brain and have a poor prognosis, while isolated intraocular relapses (IIORs) are rare and not well understood.
  • - A study analyzed 55 PCNSL patients with IIOR and found that a significant number had high IL-10 levels in their eye fluid, and the majority received systemic chemotherapy, with some undergoing high-dose chemotherapy followed by stem cell transplantation (HCT-ASCT).
  • - After an average follow-up of nearly 6 years, 76% of patients relapsed, especially those who didn't have HCT-ASCT; however, prognosis was better for IIOR compared to brain relapses, undersc
View Article and Find Full Text PDF

Background: Intravascular large B-cell lymphoma (lVLBCL) is a very rare type of large B-cell lymphoma.

Methods: We conducted a retrospective study on IVLBCL patients treated from 2000 to 2016 in LYSA cooperative group centers.

Results: Sixty-five patients were identified in 23 centers.

View Article and Find Full Text PDF

HCV cure: an appropriate moment to reduce cannabis use in people living with HIV? (ANRS CO13 HEPAVIH data).

AIDS Res Ther

March 2022

Aix Marseille Univ, Inserm, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, 35 boulevard Jean Moulin, 13005, Marseille, France.

Background: Thanks to direct-acting antivirals, hepatitis C virus (HCV) infection can be cured, with similar rates in HCV-infected and HIV-HCV co-infected patients. HCV cure is likely to foster behavioral changes in psychoactive substance use, which is highly prevalent in people living with HIV (PLWH). Cannabis is one substance that is very commonly used by PLWH, sometimes for therapeutic purposes.

View Article and Find Full Text PDF

Glial Fibrillary Acidic Protein Autoimmunity: A French Cohort Study.

Neurology

February 2022

From Service de Neurologie, Sclérose en Plaques, Pathologies de la Myéline et Neuro-Inflammation, and Centre de Référence des Maladies Inflammatoires Rares du Cerveau et de la Moelle (A.G.-D., R.M.), Service d'Imagerie Médicale (R.A.), and Centre de Référence des Syndromes Neurologiques Paranéoplasiques et Encéphalites Auto-immunes (V.R., B.J., S.M.-C., A.V., G.P., J.H.), Hôpital Neurologique Pierre Wertheimer, and Service de Neurologie Pédiatrique, Hôpital Femme Mère Enfant (C.F.), Hospices Civils de Lyon, Lyon/Bron; Institut NeuroMyoGène (V.R., B.J., S.M.-C., A.V., G.P., J.H.), INSERM 1217 et CNRS UMR5310; Université Claude Bernard Lyon 1 (V.R., B.J., S.M.-C., A.V., G.P., J.H.), Faculté de Médecine Lyon Est; Centre de Recherche en Neurosciences de Lyon (A.R., R.M.), INSERM 1028 et CNRS UMR5292, France; Stanford University Center for Sleep Sciences and Medicine (A.A.), Palo Alto, CA; Service de Neurologie Cognitive, Épilepsie, Sommeil et Mouvements Anormaux (M. Benaiteau) and Service de Neurologie Inflammatoire et Neuro-oncologie (F.R., J.C.), Hôpital Pierre-Paul Riquet, Hôpitaux de Toulouse; Service de Neuropédiatrie (K.D.), Hôpital Bicêtre, Assistance Publique-Hôpitaux de Paris, Le Kremlin-Bicêtre; Service de Neurologie (T.d.B.), Hôpital Delafontaine, Centre Hospitalier de Saint-Denis; Service de Neurologie, Hôpital de Hautepierre (L.K.), Hôpitaux Universitaires de Strasbourg; Service de Neurologie (P.K.), Centre Hospitalier de Luxembourg; Service de Neurologie (F.S.) and Service de Médecine Interne (B.B.), Hôpitaux Civils de Colmar; Unité INSERM U-1118 (F.S.), Faculté de Médecine, Université de Strasbourg; Service de Médecine Interne (R.G.), Hôpital d'Instruction des Armées Legouest, Metz; Service de Neurologie (J.B.) and Service de Médecine Interne et Immunologie Clinique (A.B.), Centre Hospitalier Régional Universitaire de Tours; Service de Neurologie et Maladies Neuromusculaires (F.D.), Groupe Hospitalier Pellegrin, Hôpitaux de Bordeaux; Service de Médecine Intensive et Réanimation (N.I.), Hôpital Saint André, Bordeaux; Service de Neurologie (E.-C.R.), Hôpital Sainte Musse, Centre Hospitalier Intercommunal de Toulon; Service de Neurologie (M.G.), Hôpital Emile Muller, Mulhouse; Service de Neurologie (A.D.), Centre Hospitalier de Perpignan; Pôle Cardio-vasculaire et Métabolique (J.L.D.), Centre Hospitalier de Cayenne; Service de Neurologie (L.H.), Hôpital Central, CHRU Nancy; Service de Neurologie (A.-L.K.), CHU de Saint-Etienne, Saint-Priest-en-Jarez; Service de Neuropédiatrie (M.P.), Site Mère Enfant, CHU Martinique, Fort-de-France; Service de Neurologie (E.C.), CHU Gabriel-Montpied, CHU de Clermont-Ferrand; Service de Neurologie (A.L.), Hôpital d'Instruction des Armées Clermont-Tonnerre, Brest; Service de Neurologie (E.M.), Hôpital Fondation Adolphe de Rothschild, Paris; Service de Neurologie et Laboratoire de Neurosciences Fonctionnelles et Pathologies (D.A.), Centre Hospitalier Universitaire d'Amiens et Université de Picardie Jules Verne, Amiens; Service de Neurologie (P.D.), Hôpital Laënnec, Centre Hospitalier de Cornouaille, Quimper; Service de Neurologie (G.M.), Centre Hospitalier Universitaire de La Réunion, Saint Pierre; Service de Neurologie (C.D.), Hôpital Roger Salengro, Centre Hospitalier Universitaire de Lille; Service de Neurologie (V.B.), Hôpital Pasteur 2, Centre Hospitalier Universitaire de Nice; Service de Médecine Interne et Maladies Infectieuses (Q.B.), Centre Hospitalier d'Angoulême; Service de Neurologie (I.G.-C.) and Service de Réanimation (G.R.), Centre Hospitalier de Saint-Brieuc; Service de Médecine Polyvalente et de Médecine Interne (D.M.-T.), Centre Hospitalier Le Mans; Service de Neurologie (M. Bonnan), Centre Hospitalier de Pau; and Service de Neurologie/UNV (T.T.), Centre Hospitalier de Saintonge, Saintes, France.

Background And Objectives: To report the clinical, biological, and imaging features and clinical course of a French cohort of patients with glial fibrillary acidic protein (GFAP) autoantibodies.

Methods: We retrospectively included all patients who tested positive for GFAP antibodies in the CSF by immunohistochemistry and confirmed by cell-based assay using cells expressing human GFAPα since 2017 from 2 French referral centers.

Results: We identified 46 patients with GFAP antibodies.

View Article and Find Full Text PDF

Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients.

Br J Dermatol

March 2022

Sorbonne Université, AP-HP, Hôpital Saint Antoine, Service de Médecine Interne et Inflammation-Immunopathology-Biotherapy Department (DMU i3), Paris, France.

Background: A new autoinflammatory syndrome related to somatic mutations of UBA1 was recently described and called VEXAS syndrome ('Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic syndrome').

Objectives: To describe clinical characteristics, laboratory findings and outcomes of VEXAS syndrome.

Methods: One hundred and sixteen patients with VEXAS syndrome were referred to a French multicentre registry between November 2020 and May 2021.

View Article and Find Full Text PDF